SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Nureca Ltd

BSE: 543264 NSE: NURECA ISIN: INE0DSF01015
  |   Sector:  Healthcare   |   Industry:  Medical Equipment/Supplies/Accessories

Snapshot

Q.1 Which industry/sub-sector does Nureca Ltd belong to?
Nureca Ltd belongs to the Healthcare sector, operating specifically within the Medical Equipment/Supplies/Accessories segment.
Q.2 Is Nureca Ltd a good quality company?
Nureca Ltd is a quality company, based on a 10 year financial track record.
Q.3 Is Nureca Ltd undervalued or overvalued?
Nureca Ltd appears Somewhat Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Nureca Ltd a good buy now?
Nureca Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Nureca Ltd?
Nureca Ltd revenue growth is 21.3% for FY-2025 , which is above its 5 year CAGR of 2.9% , indicating faster growth.
Q.2 Gross Profit margin of Nureca Ltd?
Nureca Ltd Gross profit margin which is the profit after deduction of direct costs, is 1.3% for FY-2025 , which is in line with its 5 year median of 1.3% , indicating stable margins.
Q.3 Operating Profit Margin of Nureca Ltd?
Nureca Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -8.49% for FY-2025 , which is in line with its 5 year median of -8.49% indicating stable margins.
Q.4 Net Profit Margin of Nureca Ltd?
Nureca Ltd Net Profit Margin is -0.58% for FY-2025 , is in line with with its 5 year median of -0.58%, indicating stable margins.
Current Level Historic Median
Gross Profit Margin 1.3 1.3
Operating Profit Margin -8.49 -8.49
Net Profit Margin -0.58 -0.58
Q.5 Return on Asset of Nureca Ltd?
Nureca Ltd Return on Asset is -0.33(x), which is in line with its 5 year historical median of -0.33(x), indicating stable asset utilization efficiency.
Q.6 Return on Equity (ROE) of Nureca Ltd?
Nureca Ltd Return on equity is -0.35% for FY-2025 , which is in line with its historical median of -0.35%, indicating the business is making similar use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Nureca Ltd?
Nureca Ltd Return on capital employed is 0.34% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Nureca Ltd?
Nureca Ltd Cash conversion cycle is 86 , below its historical median of 86 , indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.63 0.63
ROE -0.35 -0.35
ROCE 0.34 0.34
Cash Conversion Cycle 86 86
Q.9 Debt to Equity ratio of Nureca Ltd?
Nureca Ltd Debt-to-Equity ratio is 0.01 , which is lower with the industry average of 0.36 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Nureca Ltd?
Nureca Ltd Debt to cash flow from operations is -0.08 , which is at a unhealthy level, indicating the business is not able to service its debt comfortably.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Nureca Ltd?
Promoters hold 68.09% of the Nureca Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Nureca Ltd vs industry peers?
Nureca Ltd revenue CAGR is 2.89% , compared to the industry median CAGR of 1.45% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 114.6 36.5
Gross Profit 1.5 4.1
Operating Profit -10 3.3
Net Profit -1 2.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.63 0.73
ROE -0.35 15.79
ROCE 0.34 20.14
Cash Conversion Cycle 86.02 86

Valuation & price assessment

Q.1 Stock return of Nureca Ltd over the last decade?
Over the last 9 years, the stock has delivered a CAGR of 0% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - -22.2% -8.6% 20.5%
Q.3 Valuation ratios of Nureca Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 27.68 0.00 148.25
Price to Book 1.35 1.68 3.50
Price to Sales 1.73 2.51 3.36
EV to EBITDA 18.05 -33.53 19.40

Check more companies

1. Poly Medicure
2. Osel Devices
3. 3B Blackbio Dx
4. Laxmi Denta
5. Prevest Denpro
6. Hemant Surgical Inds
7. Yash Optics & Lens
8. Nureca Ltd.
9. Earkart
10. Raaj Medisafe India
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×